We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+43.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$517M
AUM Growth
-$20.9M
Cap. Flow
-$38.1M
Cap. Flow %
-7.37%
Top 10 Hldgs %
32.82%
Holding
87
New
12
Increased
23
Reduced
30
Closed
20

Top Sells

Rank Stock Value
1
CAR icon
Avis
CAR
+$10.6M
2
HLF icon
Herbalife
HLF
+$10.2M
3
VISN
Vistance Networks Inc
VISN
+$8.93M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.91M
5
BLK icon
Blackrock
BLK
+$8.72M

Sector Composition

Rank Sector Weight
1 Technology 18.94%
2 Healthcare 16.76%
3 Communication Services 16.19%
4 Consumer Discretionary 12.16%
5 Financials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
51
DexCom
DXCM
$34.3B
$2.99M 0.58%
126,008
-64,664
-34% -$1.37M
WMGI
52
DELISTED
Wright Medical Group Inc
WMGI
$2.99M 0.58%
+115,258
New +$2.63M
ABMD
53
DELISTED
Abiomed Inc
ABMD
$2.96M 0.57%
7,227
-3,226
-31% -$1.17M
UTHR icon
54
United Therapeutics
UTHR
$21.9B
$2.9M 0.56%
25,678
+6,732
+36% +$740K
HUM icon
55
Humana
HUM
$46.7B
$2.82M 0.55%
9,465
-480
-5% -$141K
ASND icon
56
Ascendis Pharma A/S
ASND
$16.8B
$2.81M 0.54%
42,180
-5,817
-12% -$383K
ZBH icon
57
Zimmer Biomet
ZBH
$18.7B
$2.71M 0.52%
+25,014
New +$2.72M
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$30B
$2.65M 0.51%
26,952
+4,822
+22% +$478K
SAGE
59
DELISTED
Sage Therapeutics
SAGE
$2.48M 0.48%
15,823
-16,455
-51% -$2.58M
CLVS
60
DELISTED
Clovis Oncology, Inc.
CLVS
$2.46M 0.48%
54,197
+10,436
+24% +$508K
INSM icon
61
Insmed
INSM
$28.9B
$2.39M 0.46%
101,063
+10,310
+11% +$265K
EPZM
62
DELISTED
Epizyme, Inc
EPZM
$2.36M 0.46%
173,982
+35,551
+26% +$553K
ONC
63
BeOne Medicines Ltd
ONC
$40.6B
$2.26M 0.44%
14,700
-6,096
-29% -$1.09M
DBVT
64
DBV Technologies
DBVT
$889M
$2.15M 0.42%
11,156
+1,325
+13% +$299K
NKTR icon
65
Nektar Therapeutics
NKTR
$2.57B
$1.61M 0.31%
2,197
-6,824
-76% -$7.87M
VNQ icon
66
Vanguard Real Estate ETF
VNQ
$38.6B
$1.33M 0.26%
16,353
+147
+0.9% +$11.4K
NGNE icon
67
Neurogene
NGNE
$738M
$569K 0.11%
10,738
+3,845
+56% +$1M
ALLY icon
68
Ally Financial
ALLY
$13.5B
-304,397
Closed -$8.26M
BABA icon
69
Alibaba
BABA
$300B
-46,491
Closed -$8.53M
BLK icon
70
Blackrock
BLK
$180B
-16,103
Closed -$8.72M
CAR icon
71
Avis
CAR
$4.93B
-226,378
Closed -$10.6M
VISN
72
Vistance Networks Inc
VISN
$2.67B
-223,304
Closed -$8.93M
DVA icon
73
DaVita
DVA
$11.6B
-35,345
Closed -$2.33M
EIDO icon
74
iShares MSCI Indonesia ETF
EIDO
$492M
-165,017
Closed -$4.45M
EPHE icon
75
iShares MSCI Philippines ETF
EPHE
$148M
-127,162
Closed -$4.44M

Similar funds

University of Notre Dame du Lac's Q2 2018 Portfolio in Review

As of Q2 2018, University of Notre Dame du Lac held 87 positions worth $517M, down 3.9% from $538M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

University of Notre Dame du Lac withdrew a net $38.1M in Q2 2018, closing 20 positions and reducing 30 holdings. Its most notable exit was Avis, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, University of Notre Dame du Lac opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $9.14M.

  • University of Notre Dame du Lac's largest Q2 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 202,717 shares worth $9.14M.
  • University of Notre Dame du Lac added most to Charter Communications in Q2 2018, an estimated $11.6M increase.
  • University of Notre Dame du Lac's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $8.91M.
  • University of Notre Dame du Lac fully exited Avis in Q2 2018, selling an estimated $10.6M.
  • University of Notre Dame du Lac's ten largest holdings make up 33% of its $517M portfolio in Q2 2018.
  • University of Notre Dame du Lac opened 12 new positions and closed 20 in Q2 2018.
  • University of Notre Dame du Lac's portfolio value fell 3.9% quarter-over-quarter to $517M.

Based on University of Notre Dame du Lac's 13F filing for Q2 2018, filed 14 Aug 2018.